Potassium Chloride
Severe
Database
Drug interaction classified as: absorption
Source: DDInter
Drug reference
Acrivastine
Antihistamine
Antihistamine
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
5 major
SEVERE in our sources
PREGNANCY
—
not curated
Top interactionssee all 5 →
- Potassium ChlorideSevereDatabaseDDInter
- Potassium CitrateSevereDatabaseDDInter
- Sodium OxybateSevereDatabaseDDInter
- TopiramateSevereDatabaseDDInter
Mechanism
Acrivastine is a second-generation H1-receptor antagonist that causes less sedation and psychomotor impairment compared to older antihistamines due to its slight penetration of the blood-brain barrier. It has also been shown to inhibit the P-glycoprotein transporter, though the significance of this effect is not yet known.
Indications
Nasal allergiesSeasonal allergic rhinitis (hayfever)Vasomotor rhinitisPrevention of urticariaUrticarial rashesPruritusInsect bites and stingsDrug allergies
Dosing
- Adult
- 8 mg orally
Pharmacokinetics
Duration
6-8 hours
Side effects
Common
Mild sedation
Drug interactions
Potassium Citrate
Severe
Database
Clinical effect not specified
Source: DDInter
Sodium Oxybate
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Topiramate
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Zonisamide
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
7 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.
Related guidelines
Other Antihistamine drugs
Ask House about Acrivastine
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e, Katzung, BNF·Verified: 2026-05-10 · House clinical team